fda stops tirzepatide What are the changes to regulations this month? Trade association opposes FDA decision

Identification of an intrinsic lysophosphatidic acid acyltransferase activity in the lipolytic inhibitor G0/G1 switch gene 2 (G0S2)

K.LysiukR.ShanaidaM.PeanaM.PiscopoS.et al (2025)

Whether you are using a pre-filled pen or drawing from a reconstituted vial with a syringe, the fundamental technique remains the same for subcutaneous delivery

All doses of once-weekly tirzepatide (5 mg, 10 mg, and 15 mg) were superior or non-inferior to insulin

Normal side effects like mild nausea typically improve within a few weeks of starting treatment, while gastroparesis involves persistent symptoms that may worsen over time

Neither type of evidence should be treated as interchangeable with human clinical evidence